Kura Oncology posts surging KOMZIFTI revenue and beats loss estimates
Alpha Vantage · Investing.com · · AI-summarised by FinFlash
Kura Oncology reported strong third-quarter results as KOMZIFTI net product revenue jumped 53% sequentially to Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context